
Aeterna Zentaris AEZS
Quarterly report 2025-Q4
added 05-08-2026
Aeterna Zentaris DPO Ratio 2011-2026 | AEZS
Annual DPO Ratio Aeterna Zentaris
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 34.4 K | 90.8 | 107 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.4 K | 90.8 | 11.5 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
5.06 K | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
5.24 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
74.3 | $ 33.32 | -4.81 % | $ 897 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Celyad Oncology SA
CYAD
|
55.8 K | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.73 | 4.85 % | $ 460 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.79 K | - | -4.36 % | $ 27 M | ||
|
Heron Therapeutics
HRTX
|
91.4 | $ 0.87 | 0.41 % | $ 145 M | ||
|
Compugen Ltd.
CGEN
|
82.7 | $ 2.79 | 6.9 % | $ 261 M | ||
|
Anika Therapeutics
ANIK
|
43.4 | $ 14.78 | -1.63 % | $ 212 M | ||
|
Advaxis
ADXS
|
85.6 K | - | -9.65 % | $ 45.9 M | ||
|
Incyte Corporation
INCY
|
200 | $ 96.93 | -0.5 % | $ 18.9 B | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Coherus BioSciences
CHRS
|
507 | $ 1.64 | 4.46 % | $ 192 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 20.79 | -1.05 % | $ 2.65 B | ||
|
Ampio Pharmaceuticals
AMPE
|
4.62 K | - | -11.43 % | $ 502 K |